SLE is not a one-size-fits-all disease.

Published in: The Journal of experimental medicine (2023)

In this Viewpoint we discuss how experimental medicine applied in the setting of clinical trials can address unmet need in the prototypic autoimmune disease systemic lupus erythematosus (SLE) to improve outcomes for patients.

Keyphrases

systemic lupus erythematosus
disease activity
clinical trial
end stage renal disease
newly diagnosed
multiple sclerosis
chronic kidney disease
peritoneal dialysis
rheumatoid arthritis
type diabetes
prognostic factors
patient reported outcomes
open label
glycemic control
placebo controlled
phase iii